In support of our experimental observations, NLRP3 expression prolife in various prostate tissue types (no pathological alterations vs normal adjacent of tumor vs tumor tissues or metastatic prostate cancer) did not reveal any difference, suggesting no differential expression in association with prostate cancer progression. This evidence concerns the gene NLRP3 and Familial prostate cancer.